Healthcare Triangle, Inc. is a healthcare information technology company. The company is headquartered in Pleasanton, California.
| Revenue (TTM) | $25.67M |
| Gross Profit (TTM) | $5.53M |
| EBITDA | $-13.09M |
| Operating Margin | -44.30% |
| Return on Equity | -57.40% |
| Return on Assets | -20.90% |
| Revenue/Share (TTM) | $647.86 |
| Book Value | $234.28 |
| Price-to-Book | 0.19 |
| Price-to-Sales (TTM) | 0.12 |
| EV/Revenue | 1.602 |
| EV/EBITDA | -2.92 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 158.40% |
| Shares Outstanding | 886,590 |
| Float | 494,250 |
| % Insiders | 70.72% |
| % Institutions | 0.30% |
Volatility is currently expanding
Company targeting Southeast Asia's largest economy with its Ezovion, Ziloy.ai and neurotechnology platforms and evaluating local partnership and joint venture structures. The targeted pipeline is an internal management estimate and is not contracted revenue or financial guidance.
PLEASANTON, Calif., Oct. 21, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions including managed services, cloud enablement, and data analytics for the healthcare and life sciences industries, today announced that it will effect a 1-for-20 reverse stock split of its common stock.
Six signed engagements in HCTI's Teyame business, which represent an estimated $1.34M annual full run rate; a separate unsigned opportunity targets another $3.31M. PLEASANTON, Calif.
HCTI signs MOU which details planned North American Joint Venture. The Proposed venture would deploy humanoid robots to assist with patient toileting and hygiene care, easing the physical burden on nursing teams while preserving patient dignity PLEASANTON, Calif.
The proposed acquisition of Roboticom would expand HCTI into industrial robotics and precision automation; Roboticom management's five-year forward-looking projections target $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30; the projections were provided by Roboticom management, are unaudited and unverified by HCTI, subject to significant uncertainty, and actual results may differ materially PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company") today announced it has signed a non-binding Letter of Intent ("LOI") with Crestpoint Capital LLC ("Seller") outlining a proposed transaction in which HCTI would acquire certain intellectual property, trademarks and business assets associated with Roboticom (roboticom.it), a Pisa, Italy-based provider of industrial robotic automation systems for precision surface treatment, marketed under the SandRob™, ORTIS™ and ScultoRob™ product lines and serving aerospace, marine, composites, orthotics and prosthetics, and industrial-tooling customers.
HCTI to serve as U.S. technology and capital-markets partner, bringing AI, cloud and data expertise as ARCB and Kanzun launch cross-border healthcare investment platform PLEASANTON, Calif., Sept. 17, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a U.S.-based healthcare technology company, today announced that it has signed on as the U.S. technology and capital-markets partner for a new fund built to move Malaysian healthcare companies to the world stage.
Board of Directors Approves Stock Dividend Distribution of a Minority Interest of Outstanding Common Shares of Teyame AI Holdings Inc. Common Stock to Existing HCTI Shareholders; HCTI Signs Agreement in Connection with Planned Direct Listing of Teyame AI Holdings Inc. Transaction Subject to NASDAQ Approval PLEASANTON, Calif., Sept. 3, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a healthcare technology company delivering cloud, digital transformation, and data-driven solutions to healthcare and life sciences organizations, including AI-powered customer engagement services delivering AI-powered customer engagement and digital transformation services, today announced that it has signed a separation agreement (the "Separation Agreement") with its subsidiary Teyame AI Holdings Inc. ("Teyame AI Holdings") setting forth the terms governing the planned separation (the "Separation") of Teyame AI Holdings from HCTI.
AI-Powered Customer Engagement Segment Contributed $6.31 Million in Quarterly Revenue as Stockholders' Equity Climbed to $49.1 Million from $9.9 Million PLEASANTON, Calif., Aug. 13, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a technology company delivering AI-powered customer engagement and digital transformation services, is today reporting financial results for the second quarter ended June 30, 2026, which includes second quarter revenue of $9.19 million, up 158% year over year, with gross profit up 322% to $2.07 million.
Client Has Already Matched Its Full-Year 2025 Revenue by June 2026, with Annual Turnover Projected to Reach €2 Million PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that its subsidiary, Teyame Holdings Inc. ("Teyame"), has released a progress report highlighting exceptional growth achieved on behalf of a key client — one of Spain's leading health insurance companies.
Transaction introduces 27 granted international patents, 61 pending applications , and a commercial pipeline targeting over US $50 million in cumulative revenue over three years. PLEASANTON, Calif.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on HCTI and any ticker you trade — then tracks every position and per-strategy win rate.
